Regional Health Properties (RHE)

$2.77 +0.09 (3.51%)
Market Cap 5.21M
Revenue (ttm) 17.16M
Net Income (ttm) -3.89M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -22.67%
Debt to Equity Ratio -19.45
Volume 40,200
Avg Vol 915,716
Day's Range N/A - N/A
Shares Out 1.88M
Stochastic %K 76%
Beta 1.01
Analysts Strong Buy
Price Target N/A
isaacwilliams33
isaacwilliams33 Nov. 26 at 12:50 AM
$RHE some straight vertical moment 😋
0 · Reply
Swing_Flip_Bluechip
Swing_Flip_Bluechip Nov. 25 at 4:20 PM
$MESA check out $RHE Your welcome may be a slow turn around but value there the just got a tender for $4 and rejected it for merger and cash infusion Easy play
0 · Reply
meszaros
meszaros Nov. 21 at 9:50 PM
$RHE https://www.tradingview.com/chart/RHEP/088pADGF-Fundamental-Rerating-Ahead/
0 · Reply
meszaros
meszaros Nov. 21 at 9:33 PM
$RHE The latest property sale adds a new layer to the valuation story. The Coosa Valley facility was sold for $10.6M, generating an expected ~$3.7M gain in Q4. This meaningfully strengthens the balance sheet by removing ~$4.9M debt and adding cash runway. When you combine this one-time gain with the existing Q3 EPS of ~$1.17 (annualized ~$4.68), the adjusted earnings power pushes the fair-value range much higher. Even conservative models now point to ~$42/share, while realistic valuation multiples land in the $67–84 range. Bottom line: the market hasn’t priced in the asset sale or the post-merger profitability. If RHEP maintains this trajectory, a major rerating looks inevitable.
0 · Reply
meszaros
meszaros Nov. 21 at 9:30 PM
$RHE Update on RHEP: The recent sale of the Coosa Valley facility for USD 10.6 m, yielding an expected gain of about USD 3.7 m for Q4, materially strengthens their balance sheet and earnings outlook. This isn’t just a one-off asset sale — by repaying roughly USD 4.9 m debt and adding ~USD 4.7 m cash from the transaction, the company clears leverage and frees up capital for shareholder value initiatives. Combine that with the ~USD 1.17 EPS from Q3 (annualised USD 4.68) and you’ve got a stronger case for the valuation to rerate upward. Keep this one on your radar.
0 · Reply
meszaros
meszaros Nov. 21 at 9:26 PM
$RHE Based on the latest Q3 EPS of ~$1.17, the market is massively mispricing RHEP. Annualized, that’s roughly $4.68 EPS. Even with a conservative multiple, the justified share price lands in the $37–47 range. In other words: the current valuation doesn’t reflect the company’s real earnings power after the SunLink integration. If they can maintain this profitability, a major rerating is only a matter of time.
0 · Reply
meszaros
meszaros Nov. 21 at 8:50 PM
$RHE
0 · Reply
meszaros
meszaros Nov. 21 at 8:44 PM
$RHE Based on the latest investor commentary, Regional Health Properties (RHEP) is finally showing the kind of post-merger financial strength that the market has been waiting for. The recent Q3 numbers — ~$15M revenue and ~$3.4M GAAP net income with an EPS around $1.17 — confirm that the SunLink integration materially improved both the portfolio and the operating leverage. In my view, this is the first quarter that genuinely reflects the combined entity’s earnings power. If they can maintain even a portion of this profitability, the current valuation looks extremely disconnected from fundamentals. https://seekingalpha.com/news/4524700-regional-health-properties-gaap-eps-of-1_17-revenue-of-15_14m
0 · Reply
Swing_Flip_Bluechip
Swing_Flip_Bluechip Nov. 17 at 3:34 PM
$RHE laughable liquidity cmon sell to me Buying blocks
0 · Reply
Swing_Flip_Bluechip
Swing_Flip_Bluechip Nov. 15 at 2:28 AM
$RHE My analysis indicates the common is worth $5.5+ a share based on comp sale and recent financials…. Buying all I can afford next week don’t scalp me
2 · Reply
Latest News on RHE
No data available.
isaacwilliams33
isaacwilliams33 Nov. 26 at 12:50 AM
$RHE some straight vertical moment 😋
0 · Reply
Swing_Flip_Bluechip
Swing_Flip_Bluechip Nov. 25 at 4:20 PM
$MESA check out $RHE Your welcome may be a slow turn around but value there the just got a tender for $4 and rejected it for merger and cash infusion Easy play
0 · Reply
meszaros
meszaros Nov. 21 at 9:50 PM
$RHE https://www.tradingview.com/chart/RHEP/088pADGF-Fundamental-Rerating-Ahead/
0 · Reply
meszaros
meszaros Nov. 21 at 9:33 PM
$RHE The latest property sale adds a new layer to the valuation story. The Coosa Valley facility was sold for $10.6M, generating an expected ~$3.7M gain in Q4. This meaningfully strengthens the balance sheet by removing ~$4.9M debt and adding cash runway. When you combine this one-time gain with the existing Q3 EPS of ~$1.17 (annualized ~$4.68), the adjusted earnings power pushes the fair-value range much higher. Even conservative models now point to ~$42/share, while realistic valuation multiples land in the $67–84 range. Bottom line: the market hasn’t priced in the asset sale or the post-merger profitability. If RHEP maintains this trajectory, a major rerating looks inevitable.
0 · Reply
meszaros
meszaros Nov. 21 at 9:30 PM
$RHE Update on RHEP: The recent sale of the Coosa Valley facility for USD 10.6 m, yielding an expected gain of about USD 3.7 m for Q4, materially strengthens their balance sheet and earnings outlook. This isn’t just a one-off asset sale — by repaying roughly USD 4.9 m debt and adding ~USD 4.7 m cash from the transaction, the company clears leverage and frees up capital for shareholder value initiatives. Combine that with the ~USD 1.17 EPS from Q3 (annualised USD 4.68) and you’ve got a stronger case for the valuation to rerate upward. Keep this one on your radar.
0 · Reply
meszaros
meszaros Nov. 21 at 9:26 PM
$RHE Based on the latest Q3 EPS of ~$1.17, the market is massively mispricing RHEP. Annualized, that’s roughly $4.68 EPS. Even with a conservative multiple, the justified share price lands in the $37–47 range. In other words: the current valuation doesn’t reflect the company’s real earnings power after the SunLink integration. If they can maintain this profitability, a major rerating is only a matter of time.
0 · Reply
meszaros
meszaros Nov. 21 at 8:50 PM
$RHE
0 · Reply
meszaros
meszaros Nov. 21 at 8:44 PM
$RHE Based on the latest investor commentary, Regional Health Properties (RHEP) is finally showing the kind of post-merger financial strength that the market has been waiting for. The recent Q3 numbers — ~$15M revenue and ~$3.4M GAAP net income with an EPS around $1.17 — confirm that the SunLink integration materially improved both the portfolio and the operating leverage. In my view, this is the first quarter that genuinely reflects the combined entity’s earnings power. If they can maintain even a portion of this profitability, the current valuation looks extremely disconnected from fundamentals. https://seekingalpha.com/news/4524700-regional-health-properties-gaap-eps-of-1_17-revenue-of-15_14m
0 · Reply
Swing_Flip_Bluechip
Swing_Flip_Bluechip Nov. 17 at 3:34 PM
$RHE laughable liquidity cmon sell to me Buying blocks
0 · Reply
Swing_Flip_Bluechip
Swing_Flip_Bluechip Nov. 15 at 2:28 AM
$RHE My analysis indicates the common is worth $5.5+ a share based on comp sale and recent financials…. Buying all I can afford next week don’t scalp me
2 · Reply
d_risk
d_risk Nov. 14 at 11:05 PM
$RHE - REGIONAL HEALTH PROPERTIES, INC - 10Q - Updated Risk Factors RHE flags risk to its Pharmacy DME service line from potential cuts or changes in government reimbursement and possible exposure to competitive bidding, which could impact revenues. #Healthcare #RevenueRisk #CompetitiveBidding #GovernmentReimbursement #PharmacyDME 🟢 Added 🟠 Removed https://d-risk.ai/RHE/10-Q/2025-11-14
1 · Reply
Swing_Flip_Bluechip
Swing_Flip_Bluechip Nov. 13 at 3:38 PM
$RHE going to do deep dive this weekend maybe add a significant stake here
0 · Reply
Swing_Flip_Bluechip
Swing_Flip_Bluechip Nov. 13 at 3:33 PM
$RHE I’m going to try any shares available of the company wish me luck 🍀
0 · Reply
meszaros
meszaros Nov. 12 at 1:26 PM
$RHE posted a ~$3.7 M gain (~$1.98 EPS) from its property sale. If the market applies the sector-average P/E (15–22× seen in peers like OHI, SBRA, CTRE), fair value lands between $30 – $44/share. That’s a potential +3,000 – 4,000 % upside from today’s ~$1 level.
0 · Reply
meszaros
meszaros Nov. 12 at 1:23 PM
$RHE just printed a one-time EPS boost of roughly $1.98 from the Coosa Valley sale — nearly a 3,900 % EPS explosion vs. last quarter. Even if the market prices it at a modest 2× multiple, fair value lands near $4 /share, and with a turnaround premium it could stretch into the $8–10 range.
0 · Reply
meszaros
meszaros Nov. 12 at 1:20 PM
$RHE just announced a ~$3.7 M gain from selling its Coosa Valley Health & Rehab facility. With only ~1.9 M shares outstanding, that adds roughly $1.98 EPS for the December quarter — about a 3,800 % jump vs. last quarter’s $0.05 EPS. It’s a one-time gain, but it massively improves cash and cuts debt, which could lift sentiment short-term. If management reinvests the proceeds wisely, this could mark a real turnaround story for 2026.
0 · Reply
meszaros
meszaros Nov. 12 at 1:04 PM
$RHE As things stand, RHEP may retain 10 properties. Around August 14, 2025, the company announced that it owned 11 properties (9 SNFs + 2 multi-service facilities). Of these, the Coosa Valley Health & Rehab SNF in Glencoe was sold on November 10. If this was one of the 11 (which it was), then the math is: 11 − 1 = 10 (expected to be 8 SNFs + 2 multi-service).
0 · Reply
meszaros
meszaros Nov. 12 at 1:00 PM
$RHE I see this as a moderately positive catalyst, but it is unlikely to cause an immediate explosion — however, it could improve fundamentals, and if the next steps are communicated well, it could trigger further positive movement.
0 · Reply
Swing_Flip_Bluechip
Swing_Flip_Bluechip Nov. 11 at 11:20 AM
$RHE https://markets.businessinsider.com/news/stocks/regional-health-properties-inc-reports-sale-of-skilled-nursing-facility-1035535560 I’m going to loan up on this with profit taken from elsewhere long term investment 10x easy
0 · Reply
meszaros
meszaros Nov. 5 at 4:53 PM
$RHE The pro forma financials filed in late October show that the combined Regional Health + SunLink entity is relatively asset-heavy with limited cash flexibility, and it carries a meaningful debt load. On a full-year basis, the business remains operating at a loss, with margins still under pressure. The positive net income shown in 2024 is driven mainly by a one-time bargain-purchase accounting gain, not by recurring operating performance. In 2025 so far, the merged structure continues to show operating losses.
0 · Reply
meszaros
meszaros Nov. 5 at 4:48 PM
$RHE In late October, Regional Health Properties filed an amended 8-K that included preliminary pro forma combined financials reflecting the merger with SunLink. These pro forma statements show what the financial position and results would look like as if the merger had been completed earlier. This filing doesn’t introduce new strategic information, but it does clarify the combined balance sheet structure, revenue mix, and ongoing financing obligations of the merged entity. It also confirms that the integration is now in the financial reporting phase, which is a typical post-merger step before updated guidance or restructuring initiatives are announced. The key takeaway is that the merger is operationally complete, and the market is now waiting to see whether management can stabilize margins and improve cash flow under the new capital structure.
0 · Reply
PoopHeadAli
PoopHeadAli Oct. 27 at 2:21 PM
$RHE Piece of crap stock. I should've sold months ago when it was profitable. But I thought after the merger they would be more proactive at strengthening the stock. But they've been radio silent.
0 · Reply